Update on FDA CAR-T Products and Toxicity Management Guidelines
Back to course
Video Transcription
Video Summary
Asset Subtitle
Pharmacology, 2023
Asset Caption
Type: one-hour concurrent | Evolving Landscape in Critical Care Medicine: Cellular Therapy-Related Toxicity (SessionID 1202444)
Meta Tag
Content Type Presentation
Knowledge Area Pharmacology
Membership Level Professional
Membership Level Select
Tag Toxicology
Year 2023
FDA-approved CAR T-cell products
toxicity profiles
cytokine release syndrome
neurotoxicity syndrome
IL-6 targeting with tocilizumab


Society of Critical Care Medicine

500 Midway Drive
Mount Prospect, IL 60056 USA

Phone: +1 847 827-6888
Fax: +1 847 439-7226
Email: support@sccm.org

Contact Us

About SCCM


Advertising & Sponsorship




Patients & Families

Surviving Sepsis Campaign

Critical Care Societies Collaborative

kisspng-facebook-social-media-computer-icons-linkedin-soci-gray-5ac493cf1c2975.7867418415228323351154  - KW Symphony    Gray twitter 3 icon - Free gray social icons    Gray linkedin 3 icon - Free gray site logo icons    Gray instagram icon - Free gray social icons    YouTube Icon Gray Box - HONOR VETERANS NOW


© Society of Critical Care Medicine. All rights reserved.   |    Privacy Statement    |    Terms & Conditions
The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.

Android App Download IOS App Download Powered By